Drugs / Volatile Oil of Cang-Ai
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05251779 | Nov → Dec 2022 | depressive disorder | Jieqiong Cui | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Volatile Oil of Cang-Ai | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05251779 ↗ |
| Known as | CAVO | “The test group will be given Volatile oil of Cang-Ai (hereafter referred to as CAVO) for inhalation” NCT05251779 ↗ |
| Route | Intranasal | “Via the Nose” NCT05251779 ↗ |